Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Testosterone therapy for hypogonadal men with prostate cancer

Testosterone therapy for men with prostate cancer is a controversial topic. A recent study retrospectively reviewed a single-centre experience in treating hypogonadal men with prostate cancer with exogenous testosterone therapy and found it to be safe.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Huggins, C. & Hodges, C. V. The effect of castration, of estrogen and of androgen injection on serum phosphatase on metastatic carcinoma of the prostate. Cancer Res. 1, 293–297 (1941).

    CAS  Google Scholar 

  2. Ory, J. et al. Testosterone therapy in patients with treated and untreated prostate cancer: impact on oncologic outcomes. J. Urol. http://dx.doi.org/10.1016/j.juro.2016.04.069 (2016).

  3. Zumsteg, Z. S. et al. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur. Urol. 67, 1009–1016 (2015).

    Article  Google Scholar 

  4. Kaplan, A. L. et al. Testosterone therapy in men with prostate cancer. Eur. Urol. 69, 894–903 (2016).

    Article  CAS  Google Scholar 

  5. Dohle, G. R. et al. Guidelines on male hypogonadism. European Association of Urology http://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2015.pdf (2015).

  6. Rhoden, E. L. & Morgentaler, A. Risks of testosterone-replacement therapy and recommendations for monitoring. N. Engl. J. Med. 350, 482–492 (2004).

    Article  CAS  Google Scholar 

  7. Morgentaler, A. & Traish, A. M. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur. Urol. 55, 310–321 (2009).

    Article  Google Scholar 

  8. Crawford, E. D. et al. Effects of testosterone level on lower urinary tract symptoms. Am. J. Mens Health http://dx.doi.org/10.1177/1557988315590655 (2015).

  9. Kacker, R. et al. Can testosterone therapy be offered to men on AS for prostate cancer? Preliminary results. Asian J. Androl. 17, 1–5 (2015).

    Google Scholar 

  10. San Francisco, I. F., Rojas, P. A., DeWolf, W. C. & Morgentaler, A. Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance. BJU Int. 114, 229–235 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. David Crawford.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Catarinicchia, S., Crawford, E. Testosterone therapy for hypogonadal men with prostate cancer. Nat Rev Urol 13, 497–498 (2016). https://doi.org/10.1038/nrurol.2016.118

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.118

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing